T

Bio-Techne Corp
D

TECH

64.920
USD
-0.51
(-0.78%)
مغلق
حجم التداول
61,557
الربح لكل سهم
2
العائد الربحي
0.49
P/E
66
حجم السوق
10,263,052,380
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    GOOGL
    GOOGL
    -4.895
    (-2.65%)
    179.685 USD
    IBM
    IBM
    -3.14
    (-1.18%)
    261.65 USD
    INTC
    INTC
    -1.240
    (-4.75%)
    24.850 USD
    MSFT
    MSFT
    -7.96
    (-1.91%)
    408.15 USD
    NVDA
    NVDA
    -5.850
    (-4.18%)
    134.260 USD
    ORCL
    ORCL
    -8.190
    (-4.65%)
    167.810 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    المزيد
الأخبار
المقالات

العنوان: Bio/Techne Corp

القطاع: Healthcare
الصناعة: Biotechnology
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of theworld accounting for the remaining 5%.